Author:
Schiestl Martin,Ranganna Gopinath,Watson Keith,Jung Byoungin,Roth Karsten,Capsius Björn,Trieb Michael,Bias Peter,Maréchal-Jamil Julie
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine,Biotechnology
Reference53 articles.
1. EU Directive 2004/27/EC. https://ec.europa.eu/health/files/eudralex/vol-1/dir_2004_27/dir_2004_27_en.pdf. Accessed Nov 2019.
2. Schiestl M, Zabransky M, Sörgel F. Ten years of biosimilars in Europe: development and evolution of the regulatory pathways. Drug Design Dev Ther. 2017;11:1509–15.
3. Wolff-Holz E, Tiitso K, Vleminckx, Weise M. Evolution of the EU biosimilar framework: past and future. 2019: https://doi.org/10.1007/s40259-019-00377-y.
4. Cohen HP, Blauvelt A, Rifkin RM, Danese S, Gokhale SB, Woollett G. Switching reference medicines to biosimilars: a systematic literature review of clinical outcomes. Drugs. 2018;78(4):463–78.
5. Concept paper on the development of a committee for proprietary medicinal products guideline on comparability of biotechnology-derived products. CPMP/BWP/1113/98, 24 June 1998. https://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003966.pdf. Accessed Feb 2020.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献